Equities

Utah Medical Products Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Utah Medical Products Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)64.51
  • Today's Change2.12 / 3.40%
  • Shares traded20.00k
  • 1 Year change+6.75%
  • Beta0.3494
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

  • Revenue in USD (TTM)38.63m
  • Net income in USD11.62m
  • Incorporated1978
  • Employees155.00
  • Location
    Utah Medical Products Inc7043 S 300 WestMIDVALE 84070United StatesUSA
  • Phone+1 (801) 521-5301
  • Fax+1 (801) 566-7305
  • Websitehttp://www.utahmed.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lucid Diagnostics Inc4.40m-65.84m161.04m72.00------36.61-0.8968-0.89680.05260.19730.116112.2414.9461,097.22-140.60-139.37-301.55-297.39-58.13---1,211.30-2,492.791.88--0.4633--79.00---0.6817------
Nano-X Imaging Ltd12.30m-55.71m164.03m165.00--0.9888--13.33-0.8839-0.88390.1952.400.068313.177.1874,557.58-30.95-28.17-33.30-31.20-98.04---452.82-1,072.253.93--0.0201--13.91--11.95--85.79--
Rapid Micro Biosystems Inc30.52m-44.29m166.21m163.00--3.75--5.45-0.9984-0.99840.68841.000.32091.336.40187,257.70-46.56-38.13-56.14-43.367.72-27.98-145.11-253.022.95--0.3003--24.5711.1810.63---4.24--
Apyx Medical Inc47.90m-14.54m167.34m220.00--26.39--3.49-0.3644-0.36441.190.15460.81131.973.68217,736.40-24.60-27.67-29.90-33.3562.6564.81-30.32-43.613.61-2.040.8507---8.1111.24-25.38---11.11--
Acme United Corp194.96m10.02m168.22m633.0018.151.4510.360.86282.432.4347.3530.411.152.036.35307,993.705.927.266.818.5439.5136.345.145.681.758.570.196218.401.566.42-43.6712.7033.594.56
CVRx Inc55.97m-52.02m171.68m206.00--3.57--3.07-2.02-2.022.181.830.46840.74586.49271,694.20-43.53-37.08-47.98-40.0284.4981.33-92.95-151.188.60-8.490.5072--30.5352.31-45.55--66.61--
Edap Tms SA (ADR)76.00m-23.38m183.60m310.00--6.61--2.42-0.6245-0.62452.030.7430.90812.083.62245,165.40-27.94-11.18-49.24-15.8643.2442.19-30.77-16.630.9729--0.2062--6.117.3810.20--55.92--
Accendra Health Inc6.71bn-410.53m184.86m13.50k------0.0276-5.33-17.4186.97-5.561.477.5915.52496,837.20-9.01-0.3346-17.40-0.524826.1318.20-6.12-0.1460.83861.671.25--3.553.04-778.15--34.30--
Citrine Global Corp0.00-1.74m197.47m18.00---------0.0016-0.00160.00-0.00310.00----0.00-118.80-238.43-----------186,483.40---2.10--------25.99------
Stereotaxis Inc30.07m-24.91m197.85m139.00--30.82--6.58-0.281-0.2810.33930.12660.62321.474.54216,359.70-48.96-31.30-85.25-43.3153.0762.81-78.56-56.040.8108--0.00--0.5491-1.41-14.95--2.89--
Utah Medical Products Inc38.63m11.62m198.79m155.0017.651.6913.675.153.543.5411.7536.910.3071.9210.38249,245.209.2412.089.4812.5357.1060.8830.0831.0429.36--0.0037.43-18.56-2.70-16.60-0.8254-59.491.83
OraSure Technologies Inc125.70m-60.24m202.29m501.00--0.563--1.61-0.8107-0.81071.695.010.28342.074.91250,904.20-13.08-0.8506-14.16-0.959640.4144.80-46.15-1.396.20--0.0005---54.173.75-136.34---16.43--
SANUWAVE Health Inc41.28m-7.04m219.81m46.00------5.32-0.9346-0.93464.68-0.34181.441.7511.07897,456.50-24.53-124.81----78.2671.67-17.06-144.710.8080.09991.14--59.9999.65-21.56--55.47--
Orchestra Biomed Holdings Inc2.82m-75.10m221.34m70.00--5.06--78.55-1.82-1.820.06760.77460.03130.657833.7540,257.14-83.39---104.85--93.01---2,665.05--4.72--0.2451---4.42---24.23------
KORU Medical Systems Inc39.07m-3.71m221.42m80.00--13.44--5.67-0.0807-0.08070.84820.35571.433.537.39488,383.00-13.62-19.85-18.41-23.1662.3259.62-9.50-24.861.92--0.0335--17.987.7555.85--25.82--
Electromed Inc66.22m8.20m230.28m177.0029.705.1624.473.480.92950.92957.505.351.294.042.70374,118.7015.999.3318.9911.0478.0476.5612.388.404.66--0.000.0016.9714.5346.3512.62-20.72--
Data as of Feb 10 2026. Currency figures normalised to Utah Medical Products Inc's reporting currency: US Dollar USD

Institutional shareholders

45.80%Per cent of shares held by top holders
HolderShares% Held
Brandes Investment Partners LPas of 30 Sep 2025337.93k10.55%
Renaissance Technologies LLCas of 30 Sep 2025200.91k6.27%
Dimensional Fund Advisors LPas of 30 Sep 2025191.85k5.99%
BlackRock Fund Advisorsas of 30 Sep 2025157.18k4.91%
The Vanguard Group, Inc.as of 31 Dec 2025155.68k4.86%
Hotchkis & Wiley Capital Management LLCas of 30 Sep 2025109.00k3.40%
Minerva Advisors LLCas of 30 Sep 202593.06k2.91%
Geode Capital Management LLCas of 30 Sep 202589.96k2.81%
SSgA Funds Management, Inc.as of 30 Sep 202570.26k2.19%
Rice, Hall, James & Associates LLCas of 30 Sep 202561.43k1.92%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.